Medical research

Amoeba biology reveals potential treatment target for lung disease

In a series of experiments that began with amoebas—single-celled organisms that extend podlike appendages to move around—Johns Hopkins Medicine scientists say they have identified a genetic pathway that could be activated ...

Diseases, Conditions, Syndromes

Man's Ebola relapse spawned dozens of new cases in Africa

A man in Africa who developed Ebola despite receiving a vaccine recovered but suffered a relapse nearly six months later that led to 91 new cases before he died. The report adds to evidence that the deadly virus can lurk ...

Diseases, Conditions, Syndromes

Pfizer/BioNTech first dose 85% effective after 2-4 weeks: study

The first dose of the Pfizer/BioNTech vaccination is 85 percent effective against coronavirus infection between two and four weeks after inoculation, according to a study published in the Lancet medical journal.

page 6 from 40